Filing search / scPharmaceuticals Inc. / "Death"

PRE 14A

SCPH scPharmaceuticals Inc.

12 Apr 24

Preliminary proxy

4:14pm

their earlier death, resignation or removal; To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal … to serve for a three-year term ending at the 2027 annual meeting or until his successor is elected and qualified or until his earlier death, resignation

424B5

SCPH scPharmaceuticals Inc.

23 Nov 22

Prospectus supplement for primary offering

4:15pm

of cardiovascular death, heart failure hospitalization, urgent ED/clinic visit for heart failure and the percentage change in NT-proBNP from baseline at day

424B5

gke zvjr2

21 Nov 22

Prospectus supplement for primary offering

4:05pm

8-K

EX-99.1

zzdjkuezxz

12 Jul 22

Study results favor FUROSCIX® versus “treatment as usual” in composite primary endpoint and all secondary endpoints

8:08am

DEF 14A

nwe j5asci

30 Apr 18

Definitive proxy

4:01pm